Hospital News and Research

RSS

First Edition: March 31, 2014

Today's early morning highlights from the major news organizations offer assessments of the administration's campaign to get people signed up for health care and a look at the issues going forward after today's deadline for most enrollments.

31 Mar 2014

Genetic markers could help predict heart attack in patients with heart disease

Researchers at the Intermountain Medical Center Heart Institute in Salt Lake City have identified a biological process that may help physicians predict when someone with heart disease is likely to have a heart attack in the near future.

31 Mar 2014

e-Therapeutics announces interim results from ETS2101 phase Ia trial for advanced solid tumours

e-Therapeutics plc announced today interim results from its phase Ia UK study evaluating the safety, dosing and anti-tumour activity of ETS2101 (dexanabinol) in patients with advanced solid tumours.

31 Mar 2014

Clinigen Group announces acquisition of SAVENE oncology support therapy from SpePharm

Clinigen Group plc ('Clinigen' or the 'Group') the specialty global pharmaceutical company today announces the acquisition of SAVENE® (dexrazoxane) from SpePharm AG, a majority owned affiliate of Norgine B.V. The Financial terms of the acquisition are not being disclosed.

From Clinigen Group 31 Mar 2014

Diabetic Ketoacidosis is disproportionately high among youth

Diabetic ketoacidosis (DKA), a life-threatening but preventable condition, remains an important problem for youth with diabetes and their families. Diabetic ketoacidosis is due to a severe lack of insulin and it is often the presenting symptom of type 1 diabetes. It can also be present at the onset of type 2 diabetes.

31 Mar 2014

SEATTLE II study confirms safety and efficacy of thrombolytic therapy for acute PE

EKOS Corporation, a BTG International group company, notes the presentation of the results of the SEATTLE II trial this afternoon at ACC.14, the 63rd Annual Scientific Session and Exposition of the American College of Cardiology in Washington, DC in the United States.

31 Mar 2014

Cheap drug holds promise of treating heart attack patients

The initial results of this trial were published a few months ago (Circulation. 2013;128:1495-1503), and showed that patients who received this treatment during emergency transit to hospital had much smaller amounts of dead heart muscle than those randomly assigned to receive no treatment.

31 Mar 2014

Study on effects of cholesterol-lowering medications on sexual health

A new study is giving hope to older men who are concerned about the effects of cholesterol-lowering medications on their sexual health.

31 Mar 2014

Setting clocks ahead 1 hour may accelerate cardiac events in some, shows study

Still feeling the residual effects of springing ahead for daylight saving time? The hour of sleep lost - or gained - may play a bigger, perhaps more dangerous role in our body's natural rhythm than we think. It seems moving the clock forward or backward may alter the timing of when heart attacks occur in the week following these time changes, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

31 Mar 2014

Studies reveal role of spiritual care in treating people facing serious illnesses

Two of six studies released today, reveal important advances in understanding the role of spiritual care in treating people facing serious illness, including cancer and ALS. Until now, no empirical data has existed on the contributions of chaplains in health care.

31 Mar 2014

Aspartic acid in hippocampus may be biomarker for predicting occurrence of cognitive dysfunction

Postoperative cognitive dysfunction is the deterioration of cognitive performance after anesthesia and surgery, and manifests as impairments in short-term memory, concentration, language comprehension, and social integration skills.

31 Mar 2014

AccessClosure commercially launches Mynx Ace Vascular Closure Device

AccessClosure Inc., the market leader in extravascular care technology, has commercially launched its Mynx Ace Vascular Closure Device, a safe and secure vascular closure product that provides consistent results with a new, easy-to-use deployment system to seal femoral artery access sites.

29 Mar 2014

Device to improve blood flow implanted in muscular dystrophy patient

"Today, we're going to make history," said 18-year-old Eric Ramos on the day UT Southwestern Medical Center doctors operated on his ailing heart.

29 Mar 2014

Experts in brain and spinal cord injuries to discuss treatment approaches at 23rd Annual Meeting of AMSSM

Post-concussion syndrome (PCS) and spinal cord injuries are complex problems that can present with a variety of symptoms or sequelae.

29 Mar 2014

Einstein faculty members present recent research at AACR Annual Meeting

From uncovering the role nerve cells play in metastasis to identifying new cancer-causing genes, researchers at Albert Einstein College of Medicine of Yeshiva University made notable advances in the understanding and potential treatment of cancer during the past year.

29 Mar 2014

NeuroVive presents clinical data of NVP018 for treatment of chronic hepatitis B infections at EASL

NeuroVive's anti-viral preclinical program, with compound designated NVP018, has generated significant data indicating that NVP018 has the potential to become an effective alternative or addition to current drugs for treating chronic hepatitis B infections.

29 Mar 2014

Methodist Healthcare to receive Texas Award for Performance Excellence from Quality Texas Foundation

Methodist Healthcare has been selected to receive the Texas Award for Performance Excellence (TAPE) from the Quality Texas Foundation, representing the highest level of quality an organization can achieve in the state of Texas. Methodist Healthcare is the first and only health care system in South Texas and the third organization in San Antonio to receive the TAPE award since the inception of the award in 1994.

29 Mar 2014

Study reports benefits of implementing bronchiolitis guidelines at Children's Medical Center Dallas

Bronchiolitis, the number-one cause of infant hospitalizations nationally, was the focus of a multidisciplinary effort by physicians and clinicians at Children's Medical Center Dallas to establish and implement clinical practice guidelines (CPGs) aimed at streamlining care and reducing unnecessary tests and therapies.

29 Mar 2014

Researchers describe benefits of establishing Center for Professional and Peer Support at BWH

There is a growing recognition that in health care institutions where professionalism is not embraced and expectations of acceptable behaviors are not clear and enforced, an increase in medical errors and adverse events and a deterioration in safe working conditions can occur.

29 Mar 2014

Gastric surgery reduces heart attack risk in obese people

Obese people who have stomach surgery to help them lose weight will halve their risk of heart attack according to new research from a team of doctors at the University of East Anglia, University of Manchester and University of Aberdeen.

29 Mar 2014

Hospital News and Research

First Edition: March 31, 2014

Genetic markers could help predict heart attack in patients with heart disease

e-Therapeutics announces interim results from ETS2101 phase Ia trial for advanced solid tumours

Clinigen Group announces acquisition of SAVENE oncology support therapy from SpePharm

Diabetic Ketoacidosis is disproportionately high among youth

SEATTLE II study confirms safety and efficacy of thrombolytic therapy for acute PE

Cheap drug holds promise of treating heart attack patients

Study on effects of cholesterol-lowering medications on sexual health

Setting clocks ahead 1 hour may accelerate cardiac events in some, shows study

Studies reveal role of spiritual care in treating people facing serious illnesses

Aspartic acid in hippocampus may be biomarker for predicting occurrence of cognitive dysfunction

AccessClosure commercially launches Mynx Ace Vascular Closure Device

Device to improve blood flow implanted in muscular dystrophy patient

Experts in brain and spinal cord injuries to discuss treatment approaches at 23rd Annual Meeting of AMSSM

Einstein faculty members present recent research at AACR Annual Meeting

NeuroVive presents clinical data of NVP018 for treatment of chronic hepatitis B infections at EASL

Methodist Healthcare to receive Texas Award for Performance Excellence from Quality Texas Foundation

Study reports benefits of implementing bronchiolitis guidelines at Children's Medical Center Dallas

Researchers describe benefits of establishing Center for Professional and Peer Support at BWH

Gastric surgery reduces heart attack risk in obese people

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News